Tamer Othman

17PUBLICATIONS
86CO-AUTHORS
Haematological tumoursPhysiotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 23, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.

|Jun 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|Apr 09, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Razan Mohty, Ravi Narra, Alice S Mims

|Mar 27, 2026
Impact of novel therapies on the efficacy of posttransplantation brentuximab vedotin maintenance in Hodgkin lymphoma.

Ayo Samuel Falade, Robert Redd, Sanjal H Desai

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Dec 17, 2025
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma.

Sanjal H Desai, Alison J Moskowitz, Reid W Merryman

Pageof 3

Frequent Collaborators

6 joint publications

Matthew Mei

5 joint publications

Ibrahim Aldoss

5 joint publications

Paul Koller

4 joint publications

Hoda Pourhassan